Chief Executive Officer & Managing Director, Jubilant Biosys
Giuliano has more than 20 years of experience across diverse businesses and global markets with expertise in Sales, Marketing, Strategic Planning and Business Development. His career started with Accenture and he was instrumental in providing innovative strategy for top pharma customers like Serono, Eli Lilly. Later, he worked with AstraZeneca and Euticals, held Strategic Planning and Business Development roles in cardiovascular, respiratory, gastro-intestinal, pain franchise and led global sales and marketing for APIs.
Giuliano was associated with F.I.S. FabbricaItaliana Sintetici as Chief Commercial Officer, and was responsible for strategizing and executing the company’s growth plan and ramping up the global scale-up and commercial service business. His achievement includes establishment of a new business unit, conceived and formulated a new business line and resulted in the launching of Animal Health offering. Since 2019, he is also serving as Chairman of the European Innovation Committee and Member of the Board of EFCG (European Fine Chemical Group). From 2021, he is Official co-rapporteur for the European Innovation stream at the EU ‘structured dialogue on security of medicine supply’ led by European Commission.
He is a Post Graduate in Economics, with a Thesis in Financial Mathematics, from the University of Tor, Vergata Rome, Italy and has done Strategy to Value business management course from Cranfield University – School of Management.